Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Other solid neoplasm 1Genitourinary 1Gastrointestinal 1CNS 1

Conditions

Central Nervous System Neoplasms 21Neuroblastoma 18Medulloblastoma 14Brain Neoplasms 13Astrocytoma 10Sarcoma 6Rhabdoid Tumor 6Retinoblastoma 6Ependymoma 6Oligodendroglioma 5Glioma 5Testicular Neoplasms 4Neuroectodermal Tumors, Primitive, Peripheral 4Lymphoma 4Wilms Tumor 3Teratoma 3Rhabdomyosarcoma 3Recurrence 3Pinealoma 3Ovarian Neoplasms 3Neuroectodermal Tumors, Primitive 3Liver Neoplasms 3Kidney Neoplasms 3Hepatoblastoma 3Gliosarcoma 3Glioblastoma 3Ganglioneuroblastoma 3Familial ependymoma 3Desmoplastic Small Round Cell Tumor 3Choroid Plexus Neoplasms 3

Interventions

Nivolumab 4Magnetic Resonance Spectroscopy 4fludarabine 3Fluorodeoxyglucose F18 3Cyclophosphamide 3Cisplatin 3ulixertinib 2sargramostim 2X-Rays 2Trastuzumab 2Sunitinib 2Stem Cell Transplantation 2Specimen Handling 2Sirolimus 2Oxaliplatin 2Melphalan 2Leucovorin 2FAPI-46 2Erlotinib Hydrochloride 2Cryosurgery 2Crizotinib 2Capecitabine 2Busulfan 2Bevacizumab 2trifluridine tipiracil drug combination 1trastuzumab biosimilar HLX02 1trametinib 1tipifarnib 1sapanisertib 1sacituzumab govitecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma, Hepatocellular × Thiotepa × CNS × Clear all
NCT00623077 2017-12-05

MT2004-30: Tomotherapy for Solid Tumors

Masonic Cancer Center, University of Minnesota

Phase 1 Terminated
23 enrolled
CNSGastrointestinalGenitourinaryOther solid neoplasmSarcoma

Familial ependymoma, Astrocytoma, Carcinoma, Renal Cell, Carcinoma, Hepatocellular, Kidney Neoplasms, Liver Neoplasms, Medulloblastoma, Wilms Tumor, Retinoblastoma, Sarcoma, Central Nervous System Neoplasms, Hepatoblastoma, Neuroectodermal Tumors, Primitive, Peripheral, Rhabdoid Tumor, Optic Nerve Glioma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡